Clinical significance of urokinase-type plasminogen activator (uPA) in invasive cervical cancer of the uterus
- 30 September 1992
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 46 (3) , 330-336
- https://doi.org/10.1016/0090-8258(92)90227-a
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The concentration of tissue plasminogen activator and urokinase in plasma and tissues of patients with ovarian and uterine tumorsThrombosis Research, 1990
- Plasminogen activator inhibitorsBlood, 1987
- The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type.The Journal of cell biology, 1986
- Autocrine saturation of pro-urokinase receptors on human A431 cellsCell, 1986
- Plasminogen Activators, Tissue Degradation, and CancerPublished by Elsevier ,1985
- Antibodies to plasminogen activator inhibit human tumor metastasisCell, 1983
- Alkaline phosphatase and peroxidase for double immunoenzymatic labelling of cellular constituents.Journal of Clinical Pathology, 1978
- The Peptide Chains of Human PlasminJournal of Biological Chemistry, 1967